company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11944000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11944000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1374000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3529000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,37325000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,54172000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,54172000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5411000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5411000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5411000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-833000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1640000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,807000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,807000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-532000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,49036000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,23888000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23888000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1970000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5293000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8495000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,22656000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,22656000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8059000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-17873000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16518000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9414000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9414000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-839000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4711000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3872000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3872000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,676000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,17790000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2176000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,22440000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23173000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23173000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2235000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5546000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7331000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22723000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22723000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8432000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4309000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12741000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12741000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-842000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4237000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3395000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3395000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-25000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-32094000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12523000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12523000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2279000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2810000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24297000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6685000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6685000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8363000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-960000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2250000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7073000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7073000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7281000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6244000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1037000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1037000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-36000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14831000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-137000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-137000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2412000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4377000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1990000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4662000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4662000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17358000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,49000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15809000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15809000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6808000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,21298000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-143000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14347000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14347000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,52000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3252000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,26900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2429000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,277000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7325000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,36931000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,36931000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19873000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,1033000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18340000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18340000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-566000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6224000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5704000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-46000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-46000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,10000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18555000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1740000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4280000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8022000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8022000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2373000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9382000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10107000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13840000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13840000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22329000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13731000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8598000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8598000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8203000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9841000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-388000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1250000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1250000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,32000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6524000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5543000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5543000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2536000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4908000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5351000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,18338000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,18338000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8592000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,11765000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-11765000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8592000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8592000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-467000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1792000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,348000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1673000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1673000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11418000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5620000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5620000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2770000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2364000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,35730000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,46484000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,46484000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10022000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10022000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10022000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-716000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1457000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1533000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,269000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-371000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-371000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-33000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36058000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15002000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15002000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3518000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3098000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-60637000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-39019000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-39019000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12902000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-11765000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11765000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12902000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12902000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-841000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4449000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,601000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,372000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4317000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4317000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-56235000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2137000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6537000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8805000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8805000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4163000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1564000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1548000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4626000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4626000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7679000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7679000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7679000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1117000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2112000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,995000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,995000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-118000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11428000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10356000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10356000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4209000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2040000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16223000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,32828000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,32828000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6444000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6444000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6444000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1118000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,578000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-540000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-540000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,161000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26005000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13491000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13491000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5175000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2888000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,38571000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,60125000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,60125000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20297000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-24120000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44417000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44417000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1117000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1764000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,647000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,647000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-37000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16318000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15217000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15217000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5411000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3258000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15245000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8641000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8641000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7601000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1753000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9354000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9354000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-59422000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-213000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,62000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5145000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7510000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7510000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-20000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6777000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2055000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6331000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20236000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20236000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6835000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,523000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16367000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29245000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29245000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4590000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-178167000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-182757000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-182757000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-62000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,242654000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12220000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,192874000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,192874000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19123000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5029000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5029000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8459000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2927000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5596000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10819000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10819000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4810000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4810000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4810000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1909000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1909000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1909000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7915000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,21832000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21832000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8992000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2502000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,45597000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,78923000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,78923000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5221000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5221000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5221000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,402000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,402000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,402000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,15000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,74119000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,30116000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30116000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8167000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4304000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9234000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,51821000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,51821000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16052000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1212000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-17264000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-17264000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-66000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3955000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3689000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3689000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,38250000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3761000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4711000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21520000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21520000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8532000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1681000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-51204000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-65873000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-65873000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9082000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9082000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9082000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10996000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10996000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10996000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-25000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-63984000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,14101000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14101000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8766000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2130000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22494000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2503000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2503000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10599000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10599000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10599000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4405000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6405000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6405000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,17000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1674000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,36942000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36942000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8561000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13079000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,46177000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,104759000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,104759000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13950000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13950000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13950000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3076000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3076000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3076000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-8000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,93877000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,33347000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33347000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9476000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5757000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-47452000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1128000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1128000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11181000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-650000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11831000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11831000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15014000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14914000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14914000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-134000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4077000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,7751000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,28271000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3991000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3991000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8840000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-796000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,30136000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,42171000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,42171000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18214000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18214000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18214000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4252000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4252000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4252000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,11000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,28220000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10947000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10947000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8930000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2462000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2441000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1996000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1996000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21032000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21032000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21032000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15251000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,15251000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15251000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,157000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7620000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,21340000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21340000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10385000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8355000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13004000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,27076000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,27076000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16997000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16997000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16997000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-44513000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-44513000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-44513000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-29000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-34463000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,37416000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37416000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10045000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4479000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-64591000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12651000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12651000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19957000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19957000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19957000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5210000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5210000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5210000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-39000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-27437000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,8200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10485000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10485000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10166000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4371000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16649000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,41671000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,41671000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20304000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20304000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20304000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-81000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2626000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-22707000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-22707000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1343000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4616000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4616000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9931000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4111000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,35344000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,54002000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,54002000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9301000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9301000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9301000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,767000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,765000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,765000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,45457000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,33551000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33551000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9802000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4026000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12438000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,34941000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,34941000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12776000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12776000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12776000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2469000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5730000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3261000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3261000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-62000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25364000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,33948000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33948000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12701000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3892000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,25245000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,77486000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,77486000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-90019000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-117500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-207519000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-207519000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,69000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-33017000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,229000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-32719000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-32719000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,74000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-162678000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,8400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,50100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,50100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-33300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,34600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,34600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,21000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,135300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,174000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,174000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-26100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-26100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,149100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,25100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-193500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-165800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-165800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-827700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-848500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-848500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-16200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,799100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,785900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,785900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-227800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,10200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,26600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,94700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,104800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,104800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-82800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,30000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-58400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-58400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,8900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,28500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-64500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-24100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-24100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,100000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,100100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,100100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,40200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-8900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-5000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,43200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-78600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-19700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-19700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-38200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,46900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,29700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,122100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,122100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-36100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-36100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-36100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-45000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-57900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-57900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,28200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,34500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,30800000.0
